Assessing GeneDx Holdings (WGS) Valuation After Recent Share Price Weakness
AI Sentiment
Neutral
5/10
as of 03-26-2026 9:53am EST
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
| Founded: | 2017 | Country: | United States |
| Employees: | 1300 | City: | STAMFORD |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 107.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.94 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.00 - $0.23 | Next Earning Date: | 02-18-2025 |
| Revenue: | $305,450,000 | Revenue Growth: | 50.79% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -0.00 | Index: | N/A |
| Free Cash Flow: | -33987000.0 | FCF Growth: | N/A |
WGSWW Breaking Stock News: Dive into WGSWW Ticker-Specific Updates for Smart Investing
AI Sentiment
Neutral
5/10
AI Sentiment
Highly Positive
9/10
AI Sentiment
Positive
7/10
AI Sentiment
Highly Positive
9/10
AI Sentiment
Highly Positive
8/10
See how WGSWW stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "WGSWW GeneDx Holdings Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.